John Lauerman
-
Novo, Lilly Slip As Biden Urges Price Cuts On Obesity Drugs
Novo Nordisk A/S and Eli Lilly & Co. shares fell early Tuesday after US President Joe Biden demanded price cuts on their blockbuster drugs for diabetes and weight loss.
-
Novo, Lilly Slip As Biden Urges Price Cuts On Obesity Drugs
Novo Nordisk A/S and Eli Lilly & Co. shares fell early Tuesday after US President Joe Biden demanded price cuts on their blockbuster drugs for diabetes and weight loss.
-
J&J To Buy Shockwave For $13 Billion In Medical Device Play
Johnson & Johnson agreed to acquire Shockwave Medical Inc. for about $13.1 billion in enterprise value to bolster its expansion into making medical devices to treat heart disease.
-
Pfizer Falls as Covid Pill Fails in Preventive Therapy Trial
Paxlovid is poised to become one of the fastest-selling drugs of all time, with $24 billion in projected 2022 sales.
-
All About Paxlovid and Other Covid-19 Treatments
Two pill-based treatments have emerged that even skeptical scientists are hailing as potentially huge advances.
-
Biogen to Start Screening Patients for Alzheimer’s Drug Trial
Biogen to Start Screening Patients for Alzheimer’s Drug Trial
-
Johnson & Johnson Halts Supply of Personal-Care Products in Russia
Johnson & Johnson Halts Supply of Personal-Care Products in Russia
-
Pfizer to Sell Up to 4 Million Paxlovid Doses to Poorer Nations
Pfizer to Sell Up to 4 Million Paxlovid Doses to Poorer Nations
-
WHO Exploring When and How to Declare End of Covid Emergency
The WHO said it isn’t currently considering such a declaration.
-
Merck’s Covid Pill Fumble Gives Pfizer Potential $17 Billion Win
Yet an important component of Pfizer’s antiviral has links to a drug from rival Merck: boceprevir.
-
Merck’s Covid Pill Shows Activity Against Omicron in Lab
Merck’s Covid Drug Shows Activity Against Omicron in Lab Studies
-
Merck to Supply Unicef With 3 Million Courses of Covid Therapy
Merck will supply Unicef with up to 3 million treatment courses of molnupiravir, its drug for Covid-19.
-
T Cells Triggered by Common Cold Fend Off Covid in Study
High levels of protective immune cells that fight some common colds also made people less likely to contract Covid-19 in a study.
-
Quidel to Acquire Ortho Clinical Diagnostics for $6 Billion
Quidel to Acquire Ortho Clinical Diagnostics for $6 Billion
-
NRx Soars as Drug Benefits Remdesivir-Treated Covid Patients
NRx Soars as Drug Benefits Remdesivir-Treated Covid Patients
